LOCOMOTOR EFFECTS OF LISURIDE - A CONSEQUENCE OF DOPAMINERGIC AND SEROTONERGIC ACTIONS

被引：11

作者：

FINK, H

MORGENSTERN, R

机构：

来源：

PSYCHOPHARMACOLOGY | 1985年 / 85卷 / 04期

关键词：

D O I：

10.1007/BF00429666

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：464 / 468

页数：5

共 31 条

[1] ANORECTIC EFFECT OF LISURIDE AND OTHER ERGOT DERIVATIVES IN THE RAT [J].

CARRUBA, MO ;

RICCIARDI, S ;

MULLER, EE ;

MANTEGAZZA, P .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 64 (2-3) :133-141

[2]

CARRUBA MO, 1983, LISURIDE OTHER DOPAM, P65

[3] LISURIDE HYDROGEN MALEATE - ERGOLINE WITH BETA-ADRENERGIC ANTAGONIST ACTIVITY [J].

COTE, T ;

MUNEMURA, M ;

KEBABIAN, J .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 59 (3-4) :303-306

[4] THE ROLE OF THE MEDIAN RAPHE NUCLEUS IN SULPIRIDE-INDUCED POTENTIATION OF APOMORPHINE HYPERMOTILITY [J].

FINK, H ;

MORGENSTERN, R .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 99 (01) :123-124

[5] PSYCHOTOMIMETICS POTENTIATE LOCOMOTOR HYPERACTIVITY INDUCED BY DOPAMINERGIC DRUGS [J].

FINK, H ;

MORGENSTERN, R ;

OELSSNER, W .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1979, 11 (05) :479-482

[6] CLOZAPINE - A SEROTONIN ANTAGONIST [J].

FINK, H ;

MORGENSTERN, R ;

OELSSNER, W .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1984, 20 (04) :513-517

[7] LSD, MESCALINE AND SEROTONIN INJECTED INTO MEDIAL RAPHE NUCLEUS POTENTIATE APOMORPHINE HYPERMOTILITY [J].

FINK, H ;

OELSSNER, W .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 75 (04) :289-296

[8]

FINK H, 1984, BIOGENIC AMINES

[9]

GOLD R, 1980, ACTA BIOL MED GER, V39, P917

[10]

HOLZEL B, 1984, J HIRNFORSCH, V25, P343

← 1 2 3 4 →